Celularity (CELU) Preferred Shares (2025)
Celularity's (CELU) quarterly Preferred Shares came in at $2.2 million in Q4 2025.
Analysis
Celularity (CELU) Preferred Shares (2025) Analysis & Trends
Celularity (CELU) has reported Preferred Shares for 1 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.2 million, changed N/A from the prior year.
- Preferred Shares was $2.2 million for Q4 2025 at Celularity.
- Over five years, Preferred Shares peaked at $2.2 million in Q4 2025 and troughed at $2.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 2,000.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | 2.22 Mn |